ArcherDX, which provides genomic testing products for cancer, filed on Friday with the SEC to raise up to $100 million in an initial public offering. ArcherDX is a genomics company that offers a suite ...
SOUTH SAN FRANCISCO, Calif., and COLUMBUS, Ohio, July 20, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through ...
An international pandemic notwithstanding, the cancer-focused genomic testing company ArcherDX is forging ahead with a $100 million IPO, following a busy month of pharma partnerships and FDA ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results